Growth, Health and Development in Children Born Extremely Preterm
NCT ID: NCT01150071
Last Updated: 2015-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
232 participants
OBSERVATIONAL
2010-08-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring Growth of Preterm Infants
NCT01869153
Cerebral Tissue Oxygenation in Very Low Birthweight Infants in the First 3 Days of Life
NCT01430728
Nutritional Care and Head Growth in Preterm Infants
NCT03635944
Generic Database of Moderate Preterm Infants
NCT01793116
Social Adjustment and Quality of Life After Very Preterm Birth
NCT01163188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Addtions for children born in the Western Norway Regional Health Authority:
All the children (n=52) and matched Controls born at term have measurements of height, weight and blood pressures, pulminary function tests, MRI and functional MRI of the brain, Assessment of bone mineralization and distribution of fat and muscle (DXA). Blood is collected in a biobank for assessment of inflammatory variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children born extremely preterm
national cohort of children born before 28 weeks' gestational age or with a birthweight less than 1000 g. 365 eligible survivors
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* still living when 11 years old
Exclusion Criteria
10 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haukeland University Hospital
OTHER
University of Bergen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Trond Markestad
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Trond Markestad, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Bergen, Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Stavanger University Hospital
Stavanger, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009/2271-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.